340B Health


in 340B Health News Releases

WASHINGTON, D.C.— The 340B Health Board of Directors has elected three new members representing hospitals and health systems participating in the 340B drug pricing program.

Sumona DasGupta is director for business development and strategic initiatives for the University of Washington (UW) Medicine, based in Seattle. She oversees all business development in the pharmacy department across multiple hospitals, including an academic medical center, a Level 1 trauma center, a primary care network, and a community hospital. In her oversight of UW’s 340B program, she focuses on the expansion of pharmacy services through partnerships with stakeholders and on creating pharmacy programs that increase value to patients. Previously, she served as a compliance officer for Valley Medical Center, a public hospital district, and as an attorney in the health care practice at K&L Gates. She serves on several boards, including for the Washington Immigration Defense Network, an organization that funds and facilitates representation for detained immigrants. 

Ali Santore is executive vice president, chief advocacy & social responsibility officer, for Providence, based in Renton, Wash. She leads advocacy, public affairs, and environmental sustainability for Providence, which includes managing government affairs operations across seven states and in Washington, D.C. Under her leadership, Providence has advanced social justice priorities that preserve and expand access to care for the underserved. Previously, she served in the U.S. Senate as a legislative assistant to Sen. Gordon Smith (R-Ore.) and as professional staff to the U.S. Senate Special Committee on Aging. She also was a vice president with CFM Strategic Communications, a lobbying and strategic communications firm based in Washington, D.C. Among her numerous awards, Modern Healthcare named her one of the Top 25 Emerging Leaders for 2021.

Onisis Stefas, PharmD, is vice president and chief pharmacy officer for Northwell Health, based in New Hyde Park, N.Y. He is committed to using personalized, evidence-based care through integrated pharmacy solutions to improve access to high-quality care for patients served by New York’s largest health care system. Under his leadership, Northwell subsidiary Vivo Health expanded from one retail pharmacy to 10 locations, including three accredited specialty pharmacies, a mail order pharmacy, and a 24/7 clinical call center. He frequently makes media appearances and contributes to academia though university and medical school appointments. Previously, he served in pharmacy operations for Target Corporation and CVS Health. He recently was among those featured in a New York ticker-tape parade in recognition for his strategic efforts in rolling out COVID-19 vaccines for five million New Yorkers.

“We welcome Sumona, Ali, and Onisis to the board and thank them for their dedication to bolstering the health care safety net in service to all patients in need,” said 340B Health President and CEO Maureen Testoni. “These accomplished professionals understand the patient care mission that is at the heart of 340B as well as the resources that hospitals and health systems need to fulfill that mission. We look forward to the contributions they will make to the crucial work of protecting 340B for patients with low incomes and those living in rural areas.”

Contact: Richard Sorian at richard.sorian@340bhealth.org or 202-536-2285.